Babar Ghias

Insider Reports History

Location
Durham, NC
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Babar Ghias:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOCRYST PHARMACEUTICALS INC Chief Financial Officer Common Stock 268,700 $1,862,091 $6.93 17 Dec 2025 Direct
BIOCRYST PHARMACEUTICALS INC Chief Financial Officer Emp. Stock Option (Right to Buy) 355,050 17 Dec 2025 Direct

Insider Reports Filed by Babar Ghias

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCRX BIOCRYST PHARMACEUTICALS INC 17 Dec 2025 2 $0 4 Chief Financial Officer 19 Dec 2025, 16:11
BCRX BIOCRYST PHARMACEUTICALS INC 24 Jul 2025 2 $0 4 CFO & Head of Corp Development 28 Jul 2025, 16:09
BCRX BIOCRYST PHARMACEUTICALS INC 07 Jul 2025 0 $0 3 CFO & Head of Corp Development 11 Jul 2025, 16:35